stockmarketproxy
/
BMRNNasdaq SEC EDGAR

BIOMARIN PHARMACEUTICAL INC

Pharmaceutical Preparations·NOVATO, CA·FY end 12/31·CIK 1048477
OverviewFinancialsCompensationGovernanceInsidersFilings

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Alexander HardyPresident and CEO
$1.1M$16.8M$1.9M$1.6M$409.4K$21.9M
Gregory R. FribergM.D. Executive Vice President, Chief Research & Development Officer
$705.7K$4.6M$1.3M$424.2K$153.2K$7.2M
Brian R. MuellerExecutive Vice President, CFO
$721.2K$4.3M$1.2M$565.5K$22.9K$6.8M
Cristin HubbardExecutive Vice President, Chief Commercial Officer
$662.3K$3.5M$954.8K$562.8K$69.6K$5.7M
C. Greg GuyerPh.D. Executive Vice President, Chief Technical Officer
$697.1K$3.5M$954.8K$546.0K$29.6K$5.7M

CEO pay mix

Alexander Hardy · FY 2025
Total$21.9M
Stock awards$16.8M77%
Performance bonus$1.6M7%
Salary$1.1M5%
Other$2.3M11%

Performance vs. pay

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure
FY
TSR
CEO comp
FY20
+4%
$22M
FY21
+4%
$18M
FY22
+22%
$34M
FY23
+14%
$19M
FY24
-22%
$2M

CEO comp · median worker · ratio — 5-year trend

CEO total compMedian employeePay ratio (right axis)
$24M128$18M96$12M64$6M32$0M0FY21FY22FY23FY24FY25